TNFSF13B and systemic lupus erythematosus: By investigating theassociations of BAFF and its receptors with clinical characteristics, we attempted todetermine the status and actions of BAFF in SLE, identify new biomarkers for diseaseactivity, and provide evidence for target therapy.